The compound activates a mitochondrial enzyme that regulates a cellular signaling pathway key for regeneration. The researchers saw improvements in paralysis and changes associated with neural regeneration in the mice, pointing to the compound furapyrrodole, or FP, as a possible drug candidate for further study. The findings are published in the journal Advanced Science.
“It may be possible to stimulate the body’s own repair mechanisms to restore damaged nerve cells and myelin in MS,” said Makoto Inoue, an Illinois professor of comparative biosciences who co-led the work with professors Midori Arai of Keio University and Takayoshi Arai of Chiba University. “Our findings identify FP as a promising compound that may help unlock this natural regenerative potential.”